AI assistant
Oxurion NV Capital/Financing Update 2025
3987_rns_2025-07-17_8b5a3776-cb5f-489b-b9cd-8d54a7018653.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ANNEX: Dilution Table — 17-July 2025
| 16/07/2025 | |||
|---|---|---|---|
| Share capital | 85 856 161,32 | ||
| Number of shares Par value/share (non rounded) |
12 428 021 6,90827 |
||
| 1. Voting-dividend rights dilution resulting of the Axiodis transaction and the remainder of the Atlas Funding Program afterwards | |||
| Excuding shares resulting the excise of subscription the convertible bonds which are, prent their respective sereise prices and the current stock price of the Shares, significantly out-of-the-money. |
|||
| Reference Conversion Price | Higher Conversion Price | Lower Conversion Price | |
| Hypothetical conversion prices | 0,024840 | 0,046000 | 0,009200 |
| Number of existing shares on 16-07-2025 | 12 428 021 | 12 428 021 | 12 428 02 |
| Atlas Funding Program amount regarding the Axiodis transaction (rounded to EUR 600,000) | 600 000,00 € | 600 000,00 € | 600 000,00 |
| New Shares to be issued with respect to the funding of the Axiodis transaction | 24 160 000 | 13 050 000 | 65 220 000 |
| Total shares after the funding of the Axiodis transaction | 36 588 021 | 25 478 02 | 77 648 02 |
| Dilution after funding of the Axiodis transaction under the Atlas funding program | 66,03% | 51,22% | 83,99% |
| Total shares after the funding of the Axiodis transaction | 36 588 021 | 25 478 021 | 77 648 02 |
| Conversion amount of the remaining Convertible Bonds (yet to be subscribed) | 4 300 000,00 € | 4 300 000,00 € | 4 300 000,00 € |
| New Shares to be issued upon 100% conversion of the remaining Convertible Bonds | |||
| 173 110 000 | 93 480 000 | 467 400 000 | |
| Total shares after 100% conversion of the remaining Convertible Bond | 209 698 021 | 118 958 021 | 545 048 02 |
| Dilution from the total remaining amount of 4,9M EUR under the Atlas Funding Program (including the dilution | |||
| after funding of the Axiodis transaction) | 94,07% | 89,55% | 97,72% |
| Total shares after conversion of the remaining amount under the Atlas Funding Program | 209 698 021 | 118 958 021 | 545 048 02 |
| New Shares to be issued with respect to existing Convertible Bonds | 344 210 000 | 185 870 000 | 929 350 000 |
| Total shares after 100% conversion of the existing Convertible Bonds | 553 908 021 | 304 828 021 | 1 474 398 02 |
| Total dilution from the Atlas Funding Program assuming conversion of all Convertible Bonds | 97,76% | 95,92% | 99,16% |
| 2. Financial dilution resulting from the the funding of the Axiodis transaction and the remainder of the Atlas Funding Program afterwards | |||
| Excuding have resulting for the exercised ing the convertible bonds which are, pien their respective sercise prices and the current stock | |||
| price of the Shares, significantly out-of-the-money | |||
| Reference Conversion Price | Higher Conversion Price | Lower Conversion Price | |
| Hypothetical conversion prices | 0,024840 | 0,046000 | 0,009200 |
| Before | |||
| Number of existing shares on 16-07-2025 | 12 428 021 | 12 428 023 | 12 428 02 |
| Hypothetical share price (closing price on 16 July 2025) | 0.0270 € |
0.0270 | 0,0270 |
| Market cap | € 335 556,57 |
335 556,57 | 335 556,57 |
| Market cap per share | € 0,0270 |
0,0270 | 0,0270 |
| Conversion of the Convertible Bonds pursuant to the funding of the Axiodis transaction | |||
| New Shares to be issued with respect to the funding of the Axiodis transaction | 24 160 000 | 13 050 000 | 65 220 000 |
| Cash | 600 000,00 € |
600 000,00 | 600 000,00 € |
| After | |||
| Market cap | € 935 556,57 |
€ 935 556,57 |
€ 935 556,57 |
| Number of shares Market cap per share |
36 588 021 € 0,0256 |
25 478 021 0,0367 € |
77 648 021 0,0120 € |
| Dilution after funding of the Axiodis transaction under the Atlas funding program | 5,30% | -36,00% | 55,38% |
| Market cap after step 1 | € | 935 556,57 € |
|
| Number of shares | € 935 556,57 36 588 021 |
935 556,57 25 478 021 |
77 648 021 |
| Market cap per share | C 0,0256 |
0,0367 | 0,0120 |
| Conversion remainder of the Convertible Bonds New Shares to be issued with respect to Atlas remaining amount |
|||
| 173 110 000 | 93 480 000 | 467 400 000 | |
| Conversion amount of the remaining Convertible Bonds (yet to be subscribed) | € 4 300 000,00 |
4 300 000,00 € |
4 300 000,00 |
| Alter | |||
| Market cap | C 5 235 556,57 |
€ 5 235 556,57 |
5 235 556,57 |
| Number of shares Market cap per share |
209 698 021 € 0,0250 |
118 958 021 0,0440 |
545 048 021 0,0096 |
| Dilution from the total remaining amount of 4,9M EUR under the Atlas Funding Program (including the dilution | |||
| after funding of the Axiodis transaction) | 7,53% | -63,01% | 64,42% |
| Market cap after steps 1 and 2 | € 5 235 556,57 |
€ 5 235 556,57 |
€ 5 235 556,57 |
| Number of shares | 209 698 021 | 118 958 021 | 545 048 021 |
| Market cap per share | C 0,0250 |
0,0440 € |
C 0,0096 |
| Conversion of the existing Convertible Bonds | |||
| New Shares to be issued with respect to existing Convertible Bonds | 344 210 000 | 185 870 000 | 929 350 000 |
| Cash | € | € | € |
| After | |||
| Market cap Number of shares |
€ 5 235 556,57 553 908 021 |
€ 5 235 556,57 304 828 021 |
C 5 235 556,57 1 474 398 021 |
| Market cap per share | € 0,0095 |
0,0172 € |
0,00355 C |